Page last updated: 2024-11-08

biguanides and Neurodermatitis

biguanides has been researched along with Neurodermatitis in 2 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Neurodermatitis: An extremely variable eczematous skin disease that is presumed to be a response to prolonged vigorous scratching, rubbing, or pinching to relieve intense pruritus. It varies in intensity, severity, course, and morphologic expression in different individuals. Neurodermatitis is believed by some to be psychogenic. The circumscribed or localized form is often referred to as lichen simplex chronicus.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laloux, E1
Weitgasser, H1

Trials

1 trial available for biguanides and Neurodermatitis

ArticleYear
[Experiences with a dexamethasone-nandrolonedekanoate creme].
    Wiener medizinische Wochenschrift (1946), 1972, Apr-01, Volume: 122, Issue:14

    Topics: Anti-Infective Agents, Local; Biguanides; Clinical Trials as Topic; Dermatitis; Dermatitis, Contact;

1972

Other Studies

1 other study available for biguanides and Neurodermatitis

ArticleYear
[Dermatologic study of a new ointment: Dexatopic].
    Bruxelles medical, 1971, Volume: 51, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Biguanides; Child; Child, Preschool; Dermatitis;

1971